Jakura, referred to as tofacitinib, in its 5mg dosage, represents a significant breakthrough in the management of rheumatoid arthritis (RA). This administered medication, a specific Janus kinase (JAK) inhibitor, works by interfering with the signaling pathways that contribute to inflammation and joint damage characteristic of RA. Unlike traditio… Read More